DUBAI (Reuters) – Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years from October 27, the state media office said on Tuesday.
The Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11, it also said.
(Reporting by Alexander Cornwell; Editing by Andrew Cawthorne)
